English Close

FHCI Gynecologic Oncology Physicians Participated at the Annual Meeting of the Florida Society of Gynecologic Oncology

Drs. Robert W. Holloway, Nathalie D. McKenzie, and Amanda J. Stephens participated at the 23rd Annual Meeting of the Florida Society of Gynecologic Oncology (FSGO) held June 9-11, 2017, in Long Boat Key, Florida. Dr. Holloway gave two lectures entitled: 1) Sentinel Lymph Node Mapping in Endometrial Cancer: How, When, Why?, and 2) An Update on PARP Inhibitors and Their Use in Ovarian Cancer.


FHCI Gynecologic Oncology Medical Director Robert Holloway, MD, Participated at the 2017 Sino-European Summit of Gynecologic Endoscopy in China.

Dr. Holloway was the invited keynote speaker at the 2017 Sino-European Summit of Gynecologic Endoscopy (SESGE). He addressed the congress of 3,000 participants on FHCI’s seminal research into precision sentinel lymph node mapping in endometrial cancer.


Sentinel Lymph Node Mapping and Staging in Endometrial Cancer: A Society of Gynecologic Oncology Literature Review with Consensus Recommendations Clinical Research Article Published in Gynecologic Oncology

Robert W. Holloway1, Nadeem R. Abu-Rustum2, Floor J. Backes3, John F. Boggess4, Walter H. Gotlieb5, W. Jeffrey Lowery6, Emma C. Rossi4, Edward J. Tanner7, Rebecca J. Wolsky8 1Florida Hospital Cancer Institute, Orlando, FL; 2Memorial Sloan Kettering Cancer Center, New York, NY; 3The Ohio State University Wexner Medical Center, Columbus, OH; 4University of North Carolina, Chapel Hill, NC; 5Jewish General Hospital-McGill University, Montreal, QC, Canada; 6Walter Reed National Military Medical Center, Bethesda, MD; 7Johns Hopkins Hospital-The Kelly Gynecologic Oncology Service, Baltimore, MD; 8University of California at San Francisco, San Francisco, CA

The emphasis in contemporary medical oncology has been “precision” or “personalized” medicine — terms that imply a strategy to improve efficacy through targeted therapies. Similar attempts at precision are occurring in surgical oncology. Sentinel lymph node (SLN) mapping has recently been introduced into the surgical staging of endometrial cancer with the goal to reduce morbidity associated with comprehensive lymphadenectomy, yet obtain prognostic information from lymph node status. The Society of Gynecologic Oncology’s (SGO) Clinical Practice Committee (CPC) and SLN Working Group reviewed the current literature for preparation of this document. Literaturebased recommendations for the inclusion of SLN assessment in the treatment of patients with endometrial cancer are presented.

This article examines:

  • History and various techniques of SLN mapping in endometrial cancer
  • Pathology and clinical outcomes from SLN assessment
  • Controversies and future directions for research in SLN assessment in endometrial cancer

These SGO-CPC consensus recommendations could become paradigmchanging care in endometrial cancer surgery.

For more information or to refer a patient, call GYN Oncology Care Coordinator Denise Cochran, MSN, ARNP, BC, at 407-303-5909.


Dr. Ketura Preya A. Wisner Successfully Completed Gynecologic Oncology Fellowship

Ketura Preya Ann Wisner, DO, successfully completed her three-year gynecologic oncology fellowship program at Florida Hospital Cancer Institute. Dr. Wisner has recently been accepted as an attending surgeon at Southwest Gynecologic Oncology, a private practice in Albuquerque, New Mexico. Dr. Wisner received all-round training in surgical procedures and clinical management of patients with gynecology/oncology indications and also participated in clinical outcomes research. One of her clinical outcomes research presentations “Evaluation of Sentinel Lymph Node Isolated Tumor Cells in Endometrial Cancer” was recognized with the 1st Place Poster Presentation Award at the 84th Annual Conference of the Medical Education Foundation of the American College of Osteopathic Obstetricians & Gynecologists (MEFACOOG) in Palm Desert, California, in March 2017. In addition to her clinical trainings, Dr. Wisner produced scholarly research studies, leading to three first-author publications in high-impact-factor, peer-reviewed journals.

October 16, 2017